Get started

Bullishpattern

India Glycol Ltd – Bullish Breakout Setup (Daily Timeframe)Stock: India Glycol Ltd ( NSE:INDIAGLYCO ) Trend: Bullish Momentum 🚀 | Risk-Reward: 1:3 Trade Parameters 🎯 Entry: ₹1,544 (Breakout Confirmation) 🛑 Stop Loss: ₹1,434 (Daily Closing Basis | ~7.1% Risk) 🎯 Targets: ₹1,594.40 ₹1,646.50 ₹1,700.25 ₹1,755.80 ₹1,813.10 ₹1,873.00 (Final Target) Technical Rationale ✅ Bullish Flag Breakout – Price surged out of consolidation, signaling trend continuation. ✅ RSI Strength – Daily & Weekly RSI >60 (bullish momentum confirmed). ✅ Volume Surge – Breakout volume 656K (vs. previous day’s 75K – 8.7x spike!). ✅ Risk-Reward Advantage – Final target (₹1,873) offers 1:3 reward potential relative to risk. Key Observations High-volume breakout suggests institutional/strong hands participation. Progressive targets allow for partial profit booking. Stop loss on daily closing basis reduces intraday volatility risks. Trade Management Trail SL: Move stop loss to breakeven after Target 1 is hit. Partial Booking: Secure profits incrementally at each target. Discipline: Stick to the SL level to avoid emotional trading. Disclaimer 📢 This analysis is strictly educational and does NOT constitute financial advice. Trading equities carries significant risk, including potential capital loss. Past performance is no guarantee of future results. Always conduct independent research or consult a certified financial advisor before making investment decisions. The author assumes no liability for financial outcomes based on this content. Thoughts? Are you tracking NSE:INDIAGLYCO for this setup? Comment below!
NSE:INDIAGLYCOLong
by raigvivek
SRF LTD - Weekly Pattern: The chart shows a very long period of Box Consolidation or a Rectangular Range. The price has been trading within a broad range roughly between 2,060 and 2,700 from late 2021/early 2022 until early 2025. Breakout: In early 2025, the stock has decisively broken out above the upper boundary of this multi-year consolidation range (around 2,700). Volume: There's a significant increase in volume accompanying the breakout, which is a strong bullish confirmation. Target: The height of the consolidation box (approximately 658.50 points) is projected upwards from the breakout point. This suggests a target of around 3,358.60. Support: The upper boundary of the consolidation range (around 2,700) is now a very strong support level. Resistance: The immediate resistance is the recent high around 3,060.35. The primary target is 3,358.60. Interpretation: The breakout from a multi-year consolidation on a weekly chart is a very significant bullish development. This suggests the beginning of a new, potentially strong uptrend. The stock is likely to head towards its target of 3,358.60, with the 2,700 level acting as a robust base.
NSE:SRFLong
by VCharts_TA
ADANIENT - Bulls getting ready to bump up ?????!!!Y essss!!! ! Chart patterns inculcating me the above titled opinion. 1. Monthly timeframe shows the symmetrical triangle pattern from 2020 till now, now the stock at support line(chart image shown below) 2. Weekly time frame shows us the INSIDE BAR candlestick pattern(mother baby pattern) with good volumes....with the low umtested till now.(made the low of 2025 on 22 nov 2024) 3. Daily time frame shows the Breakout attempt out of the 11 month old trendline. 4. Now, with the results on may 1, we can expect a volatile move.... .with the inverted h&s pattern around the corner. Voluminous Entry can be made after the BREAKOUT WITH GOOD VOLUMES... will update once the breakout happens. Just add it to your watchlist and keep an eye on it. THIS IS JUST MY OPINION..NOT A TIP NOR ADVICE. Thank you .
NSE:ADANIENTLong
by mmjimm
Tejas Networks: Bullish Reversal at Key Support, Targeting 1,450Trading Idea: Stock: Tejas Networks Ltd (TEJASNET) Timeframe: Daily (1D) Current Price: 704.95 INR Key Levels: Monthly Liquidity Zone: Support at around 644.65 INR. Target Zone: Potential upside towards 1,440.00 INR to 1,458.95 INR. Trade Setup: Entry: Buy around 644.65 INR (near the support level) for a possible bounce, especially if the price confirms a reversal from this level. Stop Loss: Place a stop just below 644.65 INR, considering it’s a key support zone. Target: Aim for the price to reach the target zone between 1,440 INR to 1,458.95 INR. Watch for price action at these levels for possible further action. Reasoning: The chart shows a strong sell-off followed by a potential reversal at monthly liquidity support. The CHoCH (Change of Character) pattern suggests a shift in trend direction, which could provide an opportunity for an upward move.
NSE:TEJASNETLong
by OptimaltradeX
Amazon (AMZN) Swing Trade Analysis## Amazon (AMZN) Swing Trade Analysis **Timeframe: 4H Chart (as per your screenshot, May 2, 2025)** --- ### **Technical Overview** #### **1. Price Structure** - **Trend:** The chart shows a recent reversal from a downtrend, with price making higher lows and attempting to break resistance around $190–$192. - **Support:** Strong support is visible near $178.66 and a major support at $162.49. - **Resistance/Target:** The green zone targets the $241.53–$241.86 area, which is a previous supply/resistance zone. #### **2. Indicators** - **RSI (Relative Strength Index):** - Currently around 57–58, which is neutral-bullish and not overbought. - Indicates there’s still room for upside before becoming overbought (>70). - **MACD:** - Bullish crossover recently, with the MACD line above the signal line and positive histogram. - Suggests momentum is shifting to the upside. #### **3. Risk/Reward** - **Entry:** Around $189.67 (current price). - **Stop Loss:** Below $178.66 (recent swing low/support). - **Target:** $241.53–$241.86 (previous resistance). - **Risk/Reward Ratio:** - Risk: ~$11 (from $189.67 to $178.66) - Reward: ~$52 (from $189.67 to $241.53) - **R:R ≈ 1:4.7** - Excellent for swing trading. #### **4. Volume & Volatility** - Amazon is highly liquid, ensuring good fills and manageable slippage. - The volatility is suitable for swing trading, with clear price swings and defined levels. --- ### **Why AMZN is Suitable for Swing Trading Now** - **Clear Reversal Structure:** The downtrend has paused, and higher lows are forming-a classic swing setup. - **Defined Support/Resistance:** Well-established levels allow for precise stop and target placement. - **Strong Risk/Reward:** The setup offers a high R:R ratio, which is ideal for swing trades. - **Momentum Confirmation:** Both RSI and MACD support a potential bullish move. - **No Immediate Overbought Signal:** RSI is not yet overbought, so there’s room for the trade to develop. - **Earnings Passed:** The last earnings event is behind, reducing the risk of surprise volatility. --- ### **Potential Risks** - **If price fails to break $192–$195 resistance, a pullback to support ($178.66) is possible.** - **Broader market weakness or negative news could invalidate the setup.** - **Always use a stop loss as planned.** --- ## **Conclusion & Recommendation** **Yes, AMZN is a strong candidate for a swing trade at this moment.** - The technicals, risk/reward, and liquidity all align for a textbook swing setup. - Enter above $190 with a stop below $178.66 and target $241+. - Monitor for confirmation of breakout above $192–$195 for added conviction. **(As always, manage your position size and risk according to your prop firm’s rules!)** --- **Would you like a similar analysis for any other stock?** Sources image.jpg pplx-res.cloudinary.com
NASDAQ:AMZNLong
by MasterMind_Forex_Futures
## CreditAccess Grameen (CREDITACC) Share Price Analysis- As of May 2, 2025, CreditAccess Grameen (CREDITACC) traded around ₹1,121–₹1,145, which is approximately 52% above its 52-week low of ₹750.20 (set in January 2025), but below its 52-week high of ₹1,551.95 (set in June 2024) . - The stock has shown volatility over the past year, with a notable decline from its peak, reflecting both sector trends and company-specific events . **Valuation and Financial Metrics** - **P/E Ratio (TTM):** 20.3–21.2, indicating moderate valuation relative to earnings . - **Book Value:** ₹438 per share, with the stock trading at about 2.6 times book value, which is considered on the higher side for the sector . - **Dividend Yield:** Around 0.86–0.89%, with recent dividend payouts . - **Return on Equity (ROE):** 24.8% (latest year), reflecting strong profitability . - **Return on Capital Employed (ROCE):** 14.8% . **Growth and Profitability** - The company has delivered robust profit growth (35% CAGR over the last 5 years) and strong median sales growth (31.6% over 10 years) - However, profit growth has turned negative in the trailing twelve months (-35%), primarily due to higher provisioning and write-offs in recent quarters - The company reported a loss of ₹99.5 crore in Q3 FY25, mainly due to early risk recognition, conservative provisioning, and accelerated write-offs, but management expects this to safeguard future profitability as growth normalizes **Operational Highlights** - **Assets Under Management (AUM):** Grew by 6.1% YoY to ₹24,810 crore in Q3 FY25 - **Borrower Base:** Increased by 2.4% YoY to 48.05 lakh customers - **Branch Network:** Expanded by 8.7% YoY to 2,059 branches - **Collection Efficiency:** Remained robust at 93.3% (excluding arrears) and 94.1% (including arrears), with improving trends - **Asset Quality:** PAR 90+ at 2.64%, NNPA at 1.28%, indicating some stress but manageable levels - **Capital Adequacy:** CRAR at 25.9%, reflecting a strong capital position **Strengths and Risks** **Strengths:** - Consistent long-term growth in profits and sales - Strong capital position and liquidity buffer - High collection efficiency and expanding branch network **Risks/Concerns:** - Recent decline in promoter holding (-7.42% over three years) - Low interest coverage ratio, suggesting higher financial risk - Elevated provisioning and write-offs impacting near-term profitability - Stock is trading at a premium to book value, which may limit upside if growth slows **Relative Performance** - Over the past year, the stock is down 24%, underperforming the broader market, but over five years, it has delivered a 154% return, broadly in line with sector peers - In the short term (last three months), the stock has rebounded by about 13% from its lows ## Summary CreditAccess Grameen remains a leading NBFC-MFI with a strong track record of growth and profitability. While recent quarters have seen a dip in profits due to prudent risk management and provisioning, the company’s fundamentals-such as robust capital adequacy, liquidity, and operational scale-remain intact. The stock is moderately valued but carries risks related to asset quality and sector volatility. Investors should watch for normalization of growth and profitability in upcoming quarters, as indicated by management
NSE:CREDITACCLong
by KarniKripaa
RBL bank price actionRBL Bank's stock price has shown notable activity recently, influenced by both technical and fundamental factors. Below is a detailed analysis: ## **Current Price Action** - **Latest Price**: RBL Bank's shares rose by 4.86% on March 24, 2025, reaching ₹176.40, breaking out of a consolidation range of ₹150–170 - **Technical Indicators**: The stock's breakout is supported by robust trading volumes and a daily RSI above 60, indicating bullish momentum ## **Fundamental Analysis** - **Valuation Metrics**: - P/E Ratio: 10.28 (lower than the sector average of 19.47), indicating undervaluation - P/B Ratio: 0.69, suggesting the stock is trading at a discount compared to its book value - **Intrinsic Value**: Estimated at ₹267.23, reflecting significant upside potential from the current price ## **Recent Financial Performance** - **Q3 FY25 Results**: - Revenue grew by 16% YoY to ₹4,610 crore - Net profit declined sharply by 80.7% YoY due to higher provisions for NPAs in microfinance and credit card portfolios. - Gross NPA ratio improved marginally to 2.92%, while net NPA reduced to 0.53%, indicating mixed asset quality trends ## **Long-Term Outlook** - Despite short-term challenges in profitability, RBL Bank's fundamentals remain strong, with healthy loan growth (13% YoY) and improving operational efficiency. Analysts suggest it may be suitable for long-term investment due to undervaluation and expected recovery in profitability metrics. Investors should monitor RBL Bank's asset quality trends and earnings growth closely while considering its low valuation as an attractive entry point for medium to long-term gains.
NSE:RBLBANKLong
by KarniKripaa
1
ERIS Lifesciences Share Price AnalysisEris Lifesciences is currently trading in the range of ₹1,371 to ₹1,474, with the latest reported price at ₹1,474.20 as of April 23, 2025. The stock has shown strong performance over the past year, delivering a return of approximately 57%. Over the last three months, the stock is up about 9%, though it has seen a slight dip of 0.57% in the past month. **Valuation and Fundamentals** Eris Lifesciences trades at a price-to-earnings (P/E) ratio of 57.13, which is high for the sector, and a price-to-book (P/B) ratio of 4.53. The company’s earnings per share (EPS) stands at 29.19, and its return on equity (ROE) is 12.63%, indicating moderate profitability. The market capitalization is approximately ₹18,831 crore . The dividend yield is negligible, suggesting the company focuses more on growth than on returning cash to shareholders. **Analyst Sentiment and Targets** Analyst sentiment is strongly positive, with nearly 89% recommending a buy and the remainder suggesting hold; there are no sell recommendations. The average long-term price target from analysts is ₹1,512.56, indicating modest upside from current levels. **Technical and Trading Overview** The stock has recently traded near its upper circuit of ₹1,659.60, with a lower circuit at ₹1,106.40, reflecting a relatively wide trading band and potential for volatility. Recent trading volumes have been healthy, supporting the current price momentum. **Summary** Eris Lifesciences has delivered strong returns over the past year and is viewed positively by analysts. However, its high P/E ratio suggests the stock is priced for continued growth, and the lack of dividend yield may not appeal to income-focused investors. The technical outlook is stable, with the stock trading near its highs and supported by robust trading activity.
NSE:ERISLong
by KarniKripaa
NTPC price analysisNTPC is currently trading around ₹360, having shown a modest gain of about 4% over the past year. The stock reached its all-time high of ₹448.45 in September 2024 and has since pulled back, with recent price action reflecting some consolidation after a strong multi-year rally . Over the last month, NTPC has delivered a positive return of approximately 2.5%, indicating some short-term strength despite a slight decline of nearly 1.8% in the past week. Fundamentally, NTPC remains a large-cap, stable utility with a market capitalization near ₹3.5 lakh crore and a price-to-earnings (PE) ratio of about 15.9, which is below the industry average, suggesting reasonable valuation. The company boasts a healthy dividend yield of 2.5%, and its return on equity (ROE) stands at 13.1%. Promoter holding remains steady at 51.1%, and the company continues to report strong profits, with net profit for the latest fiscal year exceeding ₹20,000 crore. Analyst sentiment is generally positive, with some brokerages forecasting up to 35% further upside from current levels and price targets ranging between ₹305 and ₹500 for 2025. Technical indicators and historical trends show NTPC often delivers positive returns in April, with an average gain of about 3% for the month In summary, NTPC is viewed as a fundamentally sound, dividend-paying stock with moderate growth prospects and reasonable valuation. While the stock is off its recent highs, the outlook remains constructive, supported by positive earnings, stable fundamentals, and favorable long-term forecasts from analysts
NSE:NTPCLong
by KarniKripaa
1
Fortis Healthcare’s share price analysisFortis Healthcare’s share price is currently around ₹667, reflecting strong momentum and significant outperformance over the past year, with a return of about 49%. The stock recently touched a 52-week high of ₹744.5 and a low of ₹406, indicating a broad trading range and robust investor interest Analyst sentiment remains bullish, with most forecasts targeting a price range of ₹736 to ₹850 over the next 12 months, suggesting a potential upside of around 10–20% from current levels . Some projections are even more optimistic, with year-end 2025 targets as high as ₹933 if market conditions remain favorable . Technical indicators currently point to a bullish trend, supporting the positive outlook . Fundamentally, Fortis Healthcare has reported strong financial results, including an 84% year-on-year jump in net profit for Q3 FY2024-25 and a 40% quarterly profit increase, underscoring operational momentum . The company trades at a price-to-earnings (PE) ratio of about 65, which is above the sector average, indicating that the stock is priced at a premium due to its growth prospects . The price-to-book (PB) ratio is 3.49, and the dividend yield is modest at 0.24% . In summary, Fortis Healthcare is in a bullish phase, supported by strong earnings growth and positive analyst outlooks. While the stock is trading at a premium valuation, its growth trajectory and sector leadership continue to attract investor interest, with further upside likely if current trends persist
NSE:FORTISLong
by KarniKripaa
## TORNTPHARM Price AnalysisTorrent Pharmaceuticals (TORNTPHARM) is currently trading near ₹3,254, maintaining a strong uptrend over the past several years. The stock has delivered a return of approximately 165% from July 2020 to November 2024, including a stock split, highlighting its consistent long-term growth. **Valuation and Fair Value** TORNTPHARM is trading well above its estimated intrinsic value. Independent valuations suggest a fair value in the range of ₹1,560 to ₹1,940 per share, meaning the current market price is overvalued by about 40%. The price-to-earnings (PE) ratio stands at approximately 59–66, which is significantly higher than the sector average of around 49, indicating a premium valuation. The price-to-book (PB) ratio is also elevated at 16, compared to the sector average of 6.29. **Recent Performance** The stock has shown positive momentum in the short term, with returns of 3.5% over the past week and 5.7% over the past month. Over the last year, TORNTPHARM has gained nearly 28%, and over three years, the return is more than 128%. Despite some volatility, the stock has outperformed many of its peers and the broader market. **Fundamental Trends** Torrent Pharma’s India business, which constitutes the bulk of its revenue, grew by 12% in Q3 FY25, driven by strong performance in branded generics. However, the company faces challenges in international markets, particularly the US, due to regulatory headwinds and pricing pressures. Revenue growth over the past five years has averaged 7% annually, slightly below the industry average, but net income growth has been robust at over 30% per year, outpacing peers. **Analyst Outlook** Analysts have a moderately positive outlook, with a one-year price target averaging around ₹3,600, and a range between ₹2,959 and ₹4,200 . About 68% of analysts currently rate the stock as a buy. **Dividend and Market Cap** The dividend yield is 0.86%, which is above the sector average, and the company’s market capitalization is approximately ₹1.1 lakh crore, placing it among the larger players in the Indian pharmaceutical sector. **Summary** TORNTPHARM has demonstrated strong long-term price appreciation and profitability, but it is currently trading at a significant premium to its estimated intrinsic value. Short-term technicals are mixed, with some bullish undertones, but caution is warranted due to high valuation multiples. The company’s growth is primarily driven by its domestic business, while international operations face ongoing challenges. Analyst sentiment remains positive, but the upside may be limited unless earnings growth accelerates or valuation multiples contract.
NSE:TORNTPHARMLong
by KarniKripaa
MAXHEALTH Price Chart Analysis**Current Price and Recent Performance** - As of the latest available data, Max Healthcare Institute Ltd (MAXHEALTH) is trading around ₹1,084.40, showing a 0.64% increase in the past 24 hours - The stock hit a high of ₹1,095.00 and a low of ₹1,066.50 in the most recent trading session, with an average traded price of ₹1,075.13 - Over the past week, the stock is down by 0.97%, but it has risen 8.23% over the past month and 30.78% over the last year **Historical Price Levels** - MAXHEALTH reached its all-time high of ₹1,227.95 on January 8, 2025 - The all-time low was ₹97.15, recorded on November 12, 2020 **Analyst Forecasts and Valuation** - Analyst price targets range from a minimum of ₹615.00 to a maximum of ₹1,390.00 - The stock is trading at a price-to-earnings (PE) ratio of 100.12 and a price-to-book (PB) ratio of 12.59, which is higher than the sector averages (sector PE: 47.87, sector PB: 6.12) - Dividend yield is low at 0.14% **Technical and Volatility Insights** - MAXHEALTH is 2.61 times as volatile as the Nifty index, indicating higher price swings. - The 50-day moving average (DMA) is at ₹1,062, suggesting the current price is above this technical support level. MAXHEALTH's valuation is high compared to peers, reflecting strong investor expectations **Fundamental Performance** - Revenue has grown at a compound annual rate of 27.47% over the last five years, outpacing the industry average of 10.01% - Net profit for FY 2023-24 was ₹687 crore, with a slight decline of 1.02% compared to the previous year, despite a 22.93% rise in revenue. - Promoter and institutional holdings have remained stable in recent quarters **Summary** MAXHEALTH has demonstrated robust long-term price appreciation and revenue growth, with a recent pullback from its all-time high. The stock trades at a premium valuation relative to sector peers, reflecting high growth expectations. Technicals show the stock is above key moving averages, and volatility remains elevated. Analyst targets suggest a broad range of possible outcomes, with the consensus leaning toward further upside, but caution is warranted due to the high valuation and recent profit stagnation
NSE:MAXHEALTHLong
by KarniKripaa
Som Distilleries & Breweries Ltd (SDBL) Price Analysis - **Current Price:** ₹156.00 (all-time high as of April 22, 2025) - **Day’s Range:** ₹127.66 – ₹143.40 - **Previous Close:** ₹128.38 - **Volume:** 13.36 million (well above 20-day average of 1.34 million) - **52-Week Range:** ₹95.61 – ₹148.90 (new all-time high today) - **VWAP:** ₹137.86 - **Market Cap:** ₹2,931 crore ### **Trend & Momentum** - SDBL has surged sharply, breaking out to a new all-time high with exceptionally high volume, indicating strong bullish momentum - The stock has rallied over 20% in a single session, moving far above recent resistance levels and its VWAP - Technical patterns suggest a bullish formation with potential for further upside, possibly another 10% move, according to chartists ### **Support & Resistance** - **Immediate Support:** ₹143.40 (today’s high), then ₹127.66 (today’s low), and ₹128.38 (previous close) - **Resistance:** With a new all-time high at ₹156.00, the stock is in price discovery; next resistance will form as the stock trades higher ### **Valuation** - **TTM PE:** 30.48 (sector PE: 88.54) - **P/B:** 4.75 - **EPS (TTM):** ₹4.67 (+5.28% YoY) - **Book Value per Share:** ₹30.02 ### **Outlook** - **Short-Term:** The breakout and volume spike suggest continued bullishness. However, after such a sharp rally, some profit booking or volatility is possible. - **Medium-Term:** Sustained trade above ₹143–₹148 keeps the trend positive. Watch for consolidation near new highs before the next leg up. - **Downside Risk:** If the stock falls below ₹143, it may retest support around ₹128–₹130
NSE:SDBLLong
by KarniKripaa
Piramal Pharma (PPLPHARMA) Stock Price Analysis**Piramal Pharma (PPLPHARMA) Indian Stock Price Analysis – April 22, 2025** - **Current Price:** ₹220.70 (as of April 21, 2025) - **Short-Term Trend:** Sideways to weak. The stock has been volatile, trading mostly between ₹217 and ₹225 in recent sessions - **Recent Performance:** - 1 week: +1.86% - 1 month: +6.36% - 3 months: –4.46% - 1 year: +55.38% - **Moving Averages:** The stock is above its 50-day moving average but below the 5-day, 20-day, 100-day, and 200-day moving averages, indicating mixed momentum and some weakness in the short term - **Support:** ₹217 - **Resistance:** ₹225–₹231 - **Volatility:** High; the stock is 3.27x as volatile as the Nifty - **Sector Comparison:** Underperforming its sector in the short term, but strong annual gains - **Analyst View:** Mixed; some analysts suggest buying for the long term, but caution is warranted in the short term due to recent weakness **Summary:** PPLPHARMA has shown strong gains over the past year but is currently consolidating with a slight bearish bias. The price is range-bound, with support at ₹217 and resistance around ₹225–₹231. Watch for a breakout above resistance for renewed bullish momentum, or a drop below support for further downside risk
NSE:PPLPHARMALong
by KarniKripaa
Bitcoin Daily Breakout – Trend Reversal in Play?BTCUSD | Breakout Alert! Bitcoin has been trading within a downward channel on the daily chart, but today it has finally broken out to the upside with strong momentum. This breakout could signal the beginning of a bullish move. If the breakout sustains above key resistance levels, BTC has significant potential to move higher in the coming days. Keep an eye on the volume and price action for confirmation. Targets & Key Levels: Next Target: 110000++ Support: 80000 Stay cautious and manage your risk accordingly! #BTCUSD #Bitcoin #CryptoBreakout #TechnicalAnalysis #CryptoTrading #BTC #CryptoCharts #BullishBreakout #PriceAction #TradingView
DELTAIN:BTCUSD.PLong
by Finnzu
Dixon Technologies Bullish Bias 10% upsideThe Stock has been consolidating for a while As visible from the RSI the stock has given a nice breakout from the range The stock price was also falling and took support near 200day EMA zone The price has reversed from the selling zone 3 days constant increase in the price and reversal with a W Breakout pattern The overall sentiment looks really bullish for the counter Also, the tariff pause shall be helping the business for a short term Looks really bullish to me. Caution: Trade as per your risk appetite.
NSE:DIXONLong
by Harshil_g
Poonawalla Fincorp | Probable Bullish Flag Breakout Candidate📊 Technical Analysis Overview: Poonawalla Fincorp is showing strong bullish momentum and is currently a probable flag breakout candidate. The stock has crossed the 200-day EMA with high volume, indicating strong institutional participation. Additionally, RSI is above 70, confirming bullish strength. 📌 Trade Setup & Key Levels ✅ Buy Entry: ₹357 🚨 Stop Loss: ₹333 🎯 Target Levels: 🔹 Target 1: ₹399.10 🔹 Target 2: ₹414.20 🔹 Target 3: ₹429.85 🔹 Target 4: ₹570.50 🔹 Target 5: ₹584.55 📈 Technical Observations 🔹 Flag Breakout Formation: The stock is attempting a breakout from a bullish flag pattern, which often leads to strong uptrends. 🔹 Volume Confirmation: A surge in volume alongside the breakout increases the probability of sustained upside. 🔹 200 DEMA Crossover: The price has successfully crossed the 200-day EMA, a strong bullish signal. 🔹 RSI Above 70: Indicates strong momentum, though a short-term pullback cannot be ruled out. ⚠️ Risk Management & Final Thoughts Always use proper risk management to protect capital. The stop loss at ₹333 ensures a controlled downside, while the upside targets provide a strong risk-reward ratio. 📢 Watch for Retest: If the price retests the ₹357 level after the breakout and holds, it could provide another buying opportunity. 📊 What do you think? Will Poonawalla Fincorp continue its rally? Share your thoughts in the comments! 👇
NSE:POONAWALLALong
by raigvivek
1
FORCEMOT Price action **Force Motors (FORCEMOT) Price Analysis – April 21, 2025** **Current Price:** ₹9,229 **Trend:** Strong uptrend, up 40% in the past three months. **Support:** ₹8,700–₹8,900 **Resistance:** ₹9,270 (previously ₹10,272, the 52-week high). **Outlook:** Bullish above ₹9,000. A breakout above ₹9,270 could potentially retest the 52-week high. **Summary:** The momentum is strong, and the trend remains positive unless the price falls below ₹8,700.
NSE:FORCEMOTLong
by KarniKripaa
1
SBI - Bullish Head and Shoulder patternState Bank of India (SBI) has completed the formation of a bullish inverse head and shoulders pattern on the daily chart — a strong technical indicator of trend reversal from bearish to bullish. Neckline Breakout: The pattern has confirmed a clean breakout above the neckline at ₹785, accompanied by rising volume, validating the breakout and signaling that buyers have taken control from sellers. Support Structure: Both the left and right shoulders of the pattern have been formed around the strong support zone of ₹725, further strengthening the reliability of this setup. Candle Confirmation: The head of the pattern was formed with a Morning Star candlestick pattern, a classic bullish reversal signal, reinforcing the likelihood of an upward move. Volume Analysis: During the formation of the head and shoulders pattern, volume was gradually declining, indicating healthy consolidation. The volume spike at the breakout point adds conviction, showing renewed interest and participation by buyers. Momentum & Moving Averages: RSI (Relative Strength Index): RSI is trading above 60, indicating strong bullish momentum without yet entering overbought territory. EMA Crossover: A bullish crossover has occurred, with the 20-day EMA crossing above the 50-day EMA, a classic trend continuation signal. The positive slope of both EMAs supports a sustained uptrend. Price Target & Risk Management: Target (as per measurement rule): The price target is calculated by measuring the distance from the bottom of the head to the neckline and projecting that from the breakout point. Estimated Upside Target: ₹880 Stop-Loss (SL) Options: Fixed SL: Below the right shoulder, around ₹730. Trailing SL: Use the 50-day EMA to dynamically protect gains as the price moves higher. Conclusion: SBI is exhibiting a strong bullish setup, with confirmation from price action, volume, and momentum indicators. The inverse head and shoulders pattern breakout, supported by key technical signals like EMA crossover and RSI strength, indicates potential for a trend continuation to the upside. Long positions can be considered with a clear risk-reward structure.
NSE:SBINLong
by Arvind_Share_Academy
STEELCAS Good VolumeStock Analysis: Steelcast Ltd (NSE: STEELCAST) Step 1: Chart Analysis & Price Action Assessment Stock recently experienced a dramatic price swing, moving from approximately ₹900 to ₹1,070 in March, followed by a sharp decline to ₹720, and now rebounding to ₹880 Currently trading at ₹880, up 14.79% for the day with significant volume (148.21K) Wide price bars in recent weeks indicate high volatility Previous trading range between ₹820-₹920 from November 2024 to February 2025 Today's large green candle suggests strong buying interest after the recent decline Step 2: Volume & Volatility Analysis Current volume (148.21K) appears significantly higher than average Volume spikes coincide with major price movements in September 2024, March 2025, and current bounce Recent price action shows extreme volatility with large candles and wide price ranges The sharp decline and subsequent rebound suggest possible shakeout pattern Step 3: Phase Classification The stock appears to be in a transitional phase with characteristics of both Stage 1 (Consolidation) and the beginning of potential Stage 2 (Accumulation) with these supporting factors: The stock experienced a Stage 3 Explosive Growth phase in March 2025 (reaching ₹1,070) Followed by a sharp correction (down to ₹720) Current price action suggests potential accumulation with today's strong bounce on high volume The previous base area (₹820-₹920) could serve as support for a new accumulation zone Step 4: Final Summary & Recommended Action Key Observations: Trend Direction: Mixed - recent correction but showing signs of stabilization Volume Behavior: Significant spike on today's rebound (148.21K) Volatility: Extremely high with recent price swings of 30%+ in both directions Support & Resistance Levels: Support around ₹800, Resistance at ₹920-₹950 Suggested Strategy: The stock appears to be transitioning from a correction into a potential new accumulation phase, but requires confirmation. Final Action Plan: CAUTIOUS BUY - The strong bounce on high volume after a sharp decline suggests possible accumulation, but the volatile nature demands caution: Consider a starter position if the stock maintains levels above ₹850 Add to the position if price stabilizes and forms a base, particularly if it can hold above the previous consolidation area (₹850-₹900) Set stop-loss below today's low or around ₹800 to manage risk in case this is just a temporary bounce Watch for continued higher volume on up days and decreased volume on down days to confirm accumulation This stock shows characteristics of a potential bottoming pattern after a correction, but its high volatility requires disciplined position sizing and risk management.
NSE:STEELCASLong
by Eswa007
4
### ICICI Bank Price Analysis (April 11, 2025)### ICICI Bank Price Analysis (April 11, 2025) #### **Current Price and Recent Trends** - **Latest Price (April 8, 2025):** ₹1,299.90 - **Intraday Movement (April 8, 2025):** - **Open:** ₹1,299.85 - **High:** ₹1,310.05 - **Low:** ₹1,287.35 - **Close:** ₹1,299.90 (+0.96% from the previous close). - **52-Week Range:** ₹1,186.00 – ₹1,373.00 #### **Performance Metrics** - **Short-Term Trends:** - April 7, 2025: Declined by -3.58% to ₹1,287.55. - April 4, 2025: Rose by +0.43% to ₹1,335.30. - **Medium-Term Trends:** - March saw fluctuations between ₹1,311 and ₹1,373. - **Long-Term Trends:** - ICICI Bank has shown consistent growth over the past year, supported by strong fundamentals. #### **Fundamental Insights** - ICICI Bank remains one of the top-performing private sector banks in India: - **Market Cap:** Over ₹9 lakh crore. - **P/E Ratio:** Competitive compared to peers in the banking sector. - **Strong Asset Quality:** Stable NPA ratios and robust loan growth. #### **Technical Analysis** - **Support Levels:** ₹1,287 (recent low) and ₹1,265 (strong support from April trends). - **Resistance Levels:** ₹1,310–₹1,320 (near-term resistance). - **Moving Averages:** - Trading slightly below the SMA20 but above SMA50 indicates potential consolidation before further movement. - **Momentum Indicators:** - RSI suggests neutral momentum with room for upward movement if market sentiment improves. #### **Sector Outlook** The banking sector is expected to benefit from: - Increased credit growth due to economic recovery. - Stable interest rate environment supporting profitability. #### **Strengths** 1. Consistent performance despite market volatility. 2. Strong fundamentals with diversified revenue streams. 3. Resilient asset quality and loan book growth. #### **Weaknesses** 1. Short-term volatility due to global banking uncertainties. 2. Resistance near ₹1,310 may limit upside in the immediate term. ### Conclusion: ICICI Bank remains a strong long-term investment option due to its robust fundamentals and leadership in the private banking space. However, short-term traders should monitor resistance levels around ₹1,310 and support near ₹1,287 for trading opportunities.
NSE:ICICIBANKLong
by KarniKripaa